SHLD2
Shieldin complex subunit 2
Also known as: bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2, SHLD2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86V20
- Gene
- SHLD2
- Ensembl
- ENSG00000122376
- Chromosome
- 10
- Canonical length
- 835 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Actin filaments
OverviewNCBI Gene
Involved in negative regulation of double-strand break repair via homologous recombination; positive regulation of double-strand break repair via nonhomologous end joining; and positive regulation of isotype switching. Located in actin cytoskeleton; nucleoplasm; and site of double-strand break. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
835 residues, UniProt reviewed canonical sequence.
>Q86V20|SHLD2
1 MSGGSQVHIF WGAPIAPLKI TVSEDTASLM SVADPWKKIQ LLYSQHSLYL KDEKQHKNLE
61 NYKVPESIGS PDLSGHFLAN CMNRHVHVKD DFVRSVSETQ NIESQKIHSS RLSDITSSNM
121 QICGFKSTVP HFTEEEKYQK LLSENKIRDE QPKHQPDICG KNFNTNLFQL GHKCAAVLDL
181 VCSTEKINIG PEVVQRECVP TEYHEIQNQC LGLFSSNAVD KSRSEAAVRK VSDLKISTDT
241 EFLSIITSSQ VAFLAQKKDK RRSPVNKGNV NMETEPKASY GEIRIPEENS IQLDGFTEAY
301 ESGQNQAYSL ELFSPVCPKT ENSRIHINSD KGLEEHTGSQ ELFSSEDELP PNEIRIELCS
361 SGILCSQLNT FHKSAIKRSC TSEDKVGQSE ALSRVLQVAK KMKLISNGGD SAVEMDRRNV
421 SEFKSIKKTS LIKNCDSKSQ KYNCLVMVLS PCHVKEINIK FGPNSGSKVP LATVTVIDQS
481 ETKKKVFLWR TAAFWAFTVF LGDIILLTDV VIHEDQWIGE TVLQSTFSSQ LLNLGSYSSI
541 QPEEYSSVVS EVVLQDLLAY VSSKHSYLRD LPPRQPQRVN SIDFVELEHL QPDVLVHAVL
601 RVVDFTILTE AVYSYRGQKQ KKVMLTVEQA QDQHYALVLW GPGAAWYPQL QRKKGVVLIK
661 AQISELAFPI TASQKIALNA HSSLKSIFSS LPNIVYTGCA KCGLELETDE NRIYKQCFSC
721 LPFTMKKIYY RPALMTAIDG RHDVCIRVES KLIEKILLNI SADCLNRVIV PSSEITYGMV
781 VADLFHSLLA VSAEPCVLKI QSLFVLDENS YPLQQDFSLL DFYPDIVKHG ANARLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SHLD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- liver: 35 nTPM
- kidney: 30 nTPM
- small intestine: 23 nTPM
- thyroid gland: 22 nTPM
- duodenum: 21 nTPM
- adrenal gland: 19 nTPM
Single-cell type
- proximal tubule cells: 243 nCPM
- distal convoluted tubule cells: 219 nCPM
- loop of henle epithelial cells: 201 nCPM
- renal collecting duct intercalated cells: 196 nCPM
- choroid plexus epithelial cells: 178 nCPM
- somatotrophs: 177 nCPM
Immune cell
- MAIT T-cell: 14 nTPM
- NK-cell: 13 nTPM
- intermediate monocyte: 12 nTPM
- myeloid DC: 11 nTPM
- T-reg: 10 nTPM
- naive CD8 T-cell: 10 nTPM
Brain region
- medulla oblongata: 72 nTPM
- midbrain: 36 nTPM
- amygdala: 34 nTPM
- thalamus: 34 nTPM
- choroid plexus: 33 nTPM
- cerebral cortex: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.31
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA repair
- negative regulation of double-strand break repair via homologous recombination
- positive regulation of double-strand break repair via nonhomologous end joining
- positive regulation of isotype switching
- regulation of double-strand break repair via homologous recombination
- somatic diversification of immunoglobulins involved in immune response
- telomere maintenance in response to DNA damage
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Shieldin complex subunit 2
- Shieldin complex subunit 2, C-terminal domain
- Shieldin complex subunit 2, first OB fold domain
- Shieldin complex subunit 2, second OB fold domain
- Shieldin complex subunit 2, C-terminal
- Shieldin complex subunit 2, first OB fold domain
- Shieldin complex subunit 2, second OB fold domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SHLD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SHLD2 as an antibody target. Whether an autoantibody or antibody against SHLD2 could matter depends on whether native SHLD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SHLD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SHLD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...